Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sernova Corp (SVA.VN)

Sernova Corp (SVA.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 399,121
  • Shares Outstanding, K 262,580
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,966 K
  • 60-Month Beta 1.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.65
Trade SVA.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings -0.02 on N/A
  • Next Earnings Date 06/24/22
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Devices

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/22
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.330 +14.29%
on 05/06/22
1.800 -15.56%
on 05/17/22
+0.120 (+8.57%)
since 04/27/22
3-Month
1.330 +14.29%
on 05/06/22
1.800 -15.56%
on 05/17/22
-0.050 (-3.18%)
since 02/25/22
52-Week
1.160 +31.03%
on 09/02/21
2.220 -31.53%
on 01/07/22
+0.260 (+20.63%)
since 05/27/21

Most Recent Stories

More News
Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes

Partnership Leverages Sernova’s Proprietary Cell Pouch System™ with Evotec’s iPSC-Based Insulin-Producing Beta CellsPartners to Develop and Commercialize...

SVA.VN : 1.520 (unch)
SEOVF : 1.2000 (+0.31%)
SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, is aware that the Company has been identified by the United States Securities...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual Report on Form 20-F

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2021 annual report on Form 20-F with the U.S. Securities...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
Sinovac Amends Shareholder Rights Plan

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited First Half of 2021 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment

SINOVAC Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today provided an update for shareholders with regard to the exchange (the “Exchange”)...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
SINOVAC Beijing Settled Litigation of Its Business License and Seals

SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced the Company’s subsidiary SINOVAC Biotech Co., Ltd (“SINOVAC...

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
Preliminary Results Show SINOVAC’s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population

SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced new preliminary data on its inactivated COVID-19 vaccine CoronaVac®....

SVA.VN : 1.520 (unch)
SVA : 6.47 (-0.31%)
Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SHGFF : 5.6450 (+1.71%)
BABYF : 1.0800 (+1.89%)
CRTPF : 2.3000 (+5.50%)
VVIVF : 0.2210 (-5.56%)
AVCNF : 0.3145 (+11.60%)
ORXOY : 1.8800 (+2.73%)
DOC.VN : 0.410 (-3.53%)
SVA.VN : 1.520 (unch)
SHG.VN : 6.800 (+5.92%)
BABY.VN : 1.170 (unch)
Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Sernova invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com

OTCM : 56.8000 (+1.81%)
SEOVF : 1.2000 (+0.31%)
SVA.VN : 1.520 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.597
2nd Resistance Point 1.573
1st Resistance Point 1.547
Last Price 1.520
1st Support Level 1.497
2nd Support Level 1.473
3rd Support Level 1.447

See More

52-Week High 2.220
Fibonacci 61.8% 1.815
Fibonacci 50% 1.690
Fibonacci 38.2% 1.565
Last Price 1.520
52-Week Low 1.160

See More

Business Summary

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar